Balazs Halmos

36PUBLICATIONS
236CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Aug 28, 2026
Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non-Small Cell Lung Cancer.

|Aug 08, 2026
Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma.

|Jun 08, 2026
Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.

|Feb 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities.

Sonam Puri, Andrew Elliott, Abdul Rafeh Naqash

|Feb 10, 2026
Targeting NHEJ activates STING signaling through MYC degradation to boost antitumor immunity in SCLC.

Subhamoy Chakraborty, Andrew Elliott, Utsav Sen

|Feb 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.

Joshua E Reuss, Lyudmila Bazhenova, Nofisat Ismaila

Pageof 6

Frequent Collaborators

6 joint publications

Nofisat Ismaila

6 joint publications

Janet Freeman-Daily

6 joint publications

Dwight H Owen

6 joint publications

Lyudmila Bazhenova